Document is current
Any future updates will be listed below
-
Authors
Möller, Katharina
Gulzar, Tayyaba
Lennartz, Maximilian
Viehweger, Florian
Kluth, Martina
Hube-Magg, Claudia
Bernreuther, Christian
Bawahab, Ahmed Abdulwahab
Simon, Ronald https://orcid.org/0000-0003-0158-4258
Clauditz, Till S.
Sauter, Guido
Schlichter, Ria
Hinsch, Andrea
Kind, Simon
Jacobsen, Frank
Burandt, Eike
Frost, Nikolaj
Reck, Martin
Marx, Andreas H.
Krech, Till
Lebok, Patrick
Fraune, Christoph
Steurer, Stefan
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 20 August 2024
Revised: 20 August 2024
Accepted: 6 September 2024
First Online: 8 October 2024
Declarations
:
: The usage of archived diagnostic left-over tissues for manufacturing of TMAs and their analysis for research purposes as well as patient data analysis has been approved by local laws (HmbKHG, §12,1) and by the local ethics committee (Ethics commission Hamburg, WF-049/09). All work has been carried out in compliance with the Helsinki Declaration.
: The recombinant rabbit monoclonal TTF-1-antibody clone MSVA-312R was provided by MS Validated Antibodies GmbH, Hamburg, Germany (owned by a family member of GS).
